Literature DB >> 27231336

Translation and cultural appropriateness of the Autism Diagnostic Observation Schedule-2 in Afrikaans.

Lesia Smith1,2, Susan Malcolm-Smith1, Petrus J de Vries2.   

Abstract

Autism Diagnostic Observation Schedule-2 is the 'gold standard' autism spectrum disorder observational assessment, and it is increasingly used in South Africa. However, its use is limited to English speakers, as it has not been translated into the country's other 10 official languages. Moreover, the cultural appropriateness of this tool has not been explored in South Africa. The Autism Diagnostic Observation Schedule-2 was translated into Afrikaans and assessed for cultural appropriateness to the 'coloured' population from low-middle socioeconomic status backgrounds in the Western Cape Province. Using a mixed-methods approach, three components associated with method bias in the Autism Diagnostic Observation Schedule-2 were investigated: language used, social interactions and activities, and materials. An ethnographic investigation of play, social interaction and social activities was conducted in a community sample ( n = 40), and the Afrikaans Autism Diagnostic Observation Schedule-2 was pre-piloted in a clinical sample ( n = 7). Results highlighted unique aspects of the language ('Kaaps') that need to be considered during Autism Diagnostic Observation Schedule-2 administration. The social interaction demands of the Autism Diagnostic Observation Schedule-2 appeared appropriate, and sufficient familiarity with Autism Diagnostic Observation Schedule-2 materials and activities was found to support the use of the Autism Diagnostic Observation Schedule-2. Guidelines for administration of the Autism Diagnostic Observation Schedule-2 to this population were generated to improve cultural sensitivity and cultural appropriateness and to reduce method bias.

Entities:  

Keywords:  Autism Diagnostic Observation Schedule-2; South Africa; Western Cape; autism spectrum disorder; cultural appropriateness; ethnography of play

Mesh:

Year:  2016        PMID: 27231336     DOI: 10.1177/1362361316648469

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  7 in total

Review 1.  Autism spectrum disorder in sub-saharan africa: A comprehensive scoping review.

Authors:  Lauren Franz; Nola Chambers; Megan von Isenburg; Petrus J de Vries
Journal:  Autism Res       Date:  2017-03-07       Impact factor: 5.216

2.  Caregiver descriptions of joint activity routines with young children with autism spectrum disorder in South Africa.

Authors:  Kevin Ramseur; Petrus J de Vries; Jessy Guler; Nokuthula Shabalala; Noleen Seris; Lauren Franz
Journal:  Pediatr Med       Date:  2019-03-13

3.  The diagnosis of autism and autism spectrum disorder in low- and middle-income countries: Experience from Jamaica.

Authors:  Maureen Samms-Vaughan; Mohammad H Rahbar; Aisha S Dickerson; Katherine A Loveland; Manouchehr Hessabi; Deborah A Pearson; Jan Bressler; Sydonnie Shakespeare-Pellington; Megan L Grove; Charlene Coore-Desai; Jody Reece; Eric Boerwinkle
Journal:  Autism       Date:  2017-04-01

Review 4.  A Systematic Review of Research on Autism Spectrum Disorders in Sub-Saharan Africa.

Authors:  Amina Abubakar; Derrick Ssewanyana; Charles R Newton
Journal:  Behav Neurol       Date:  2016-10-30       Impact factor: 3.342

5.  The Bidirectional Social-Cognitive Mechanisms of the Social-Attention Symptoms of Autism.

Authors:  Peter Mundy; Jenifer Bullen
Journal:  Front Psychiatry       Date:  2022-01-31       Impact factor: 4.157

6.  Adaptation and validation of two autism-related measures of skills and quality of life in Ethiopia.

Authors:  Anton Borissov; Ioannis Bakolis; Bethlehem Tekola; Mersha Kinfe; Caterina Ceccarelli; Fikirte Girma; Rehana Abdurahman; Tigist Zerihun; Charlotte Hanlon; Rosa A Hoekstra
Journal:  Autism       Date:  2021-12-07

Review 7.  The Diagnosis of Autism: From Kanner to DSM-III to DSM-5 and Beyond.

Authors:  Nicole E Rosen; Catherine Lord; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2021-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.